Lantheus Holdings Inc. - notizie pubblicate 272 - letture 4.228
LANTHEUS HOLDINGS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
LANTHEUS HOLDINGS INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
LANTHEUS HOLDINGS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
LANTHEUS HOLDINGS INC.
Quarterly Report for Quarter Ending June 30, 2024 (Form 10-Q)
Lnth-20240630 table of contents united states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) ☑ quarterly report pursuant to section 13 or 15(d) of ...
LANTHEUS HOLDINGS INC.
Lantheus Reports Second Quarter 2024 Financial Results Form 8 K
Lantheus reports second quarter 2024 financial results second quarter 2024 •worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 •completed three ...
LANTHEUS HOLDINGS INC.
2Q 2024 Reconciliation of GAAP to Non-GAAP Financial Measures
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer lantheus holdings in ...
LANTHEUS HOLDINGS INC.
Selected Historical Financial Results
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer lantheus holdings in ...
LANTHEUS HOLDINGS INC.
Lantheus Reports Second Quarter 2024 Financial Results
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer lantheus holdings in ...
LANTHEUS HOLDINGS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
LANTHEUS HOLDINGS INC.
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
Lantheus to host second quarter 2024 earnings conference call and webcast on july 31, 2024, at 8:00 a.m. eastern time july 17, 2024 at 8:30 am edt bedford, mass., july 17, 2024 (gl ...
LANTHEUS HOLDINGS INC.
Lantheus Acquires NAV 4694, a Next Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
Lantheus acquires nav-4694, a next-generation ß amyloid pet imaging agent for alzheimer's disease july 15, 2024 at 8:30 am edt acquisition expands pipeline and strengthens alzheim ...
LANTHEUS HOLDINGS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
LANTHEUS HOLDINGS INC.
Lantheus Appoints Jamie Spaeth as Chief People Officer
Lantheus appoints jamie spaeth as chief people officer july 8, 2024 at 8:30 am edt bedford, mass., july 08, 2024 (globe newswire) -- lantheus holdings, inc. ("lantheus") ...
LANTHEUS HOLDINGS INC.
Lantheus Acquires Global Rights to Life Molecular Imaging's Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers Form 8 K
Lantheus acquires global rights to life molecular imaging's novel therapeutic and diagnostic pair targeting grpr for prostate and breast cancers deal further strengthens lantheus' ...
LANTHEUS HOLDINGS INC.
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
Lantheus acquires global rights to life molecular imaging's novel therapeutic and diagnostic pair targeting grpr for prostate and breast cancers june 27, 2024 at 7:05 am edt deal f ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti